A late-stage trial found a new pill, daraxonrasib, doubled median survival and improved quality of life, compared with chemotherapy, for advanced pancreatic cancer patients.
A coronavirus strain known as BA.3.2 has been detected in multiple countries, including the U.S., prompting close monitoring as health officials weigh the risk of a spring or summer surge.